Target intelligence / Profile preview

microRNA 4719 (miR-4719)

Target
miR-4719
Molecular classification
Other, microRNA, non-coding RNA
01

Overview

microRNA 4719 (miR-4719, hsa-mir-4719, MIR4719) is a small non-coding RNA molecule classified as a microRNA, which regulates target gene expression by binding to complementary sequences in messenger RNA (mRNA), mainly leading to mRNA degradation or inhibition of translation. miR-4719 has been identified as a post-transcriptional regulator of Interleukin-24 (IL-24) by binding to the 3’ untranslated region (3’UTR) of its mRNA. In prostate cancer, miR-4719 is significantly overexpressed in castration-resistant prostate cancer (CRPC) cell lines compared to indolent and normal prostate cells. Overexpression of miR-4719 reduces IL-24 levels, thereby promoting increased cancer cell proliferation and migration; conversely, inhibition of miR-4719 increases IL-24 and suppresses these cancerous behaviors. miR-4719 may serve as a candidate biomarker for aggressive disease and has potential diagnostic and therapeutic value for risk stratification and management in prostate cancer, especially in the context of racial disparities[1][2].

Other names
hsa-mir-4719MIR4719
02

Mechanism of action

Not applicable (miR-4719 acts by binding target mRNA 3’UTR to decrease gene expression, specifically Interleukin-24/IL-24 mRNA)

03

Biological functions

Post-transcriptional gene regulationRegulation of mRNA stabilityModulation of cell proliferationModulation of cell migration
04

Disease associations

Cancer (Prostate cancer, especially castration-resistant prostate cancer)Biomarker potential (progression, racial disparity in prostate cancer)
05

Safety considerations

Therapeutic targeting of microRNAs may encounter challenges such as off-target gene regulationdelivery of miRNA mimics/inhibitorspotential for broad systemic effects (general to miRNA therapeutics, not specifically miR-4719)
06

Biomarkers

Diagnostic biomarker for distinguishing indolent from aggressive (castration-resistant) prostate cancerstratification of prostate cancer progression and racial disparity

Beyond the preview

Go deeper on microRNA 4719 (miR-4719).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 4719 (miR-4719).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call